Evidence map›Paper›PMID 35265098›Full record

ArticleFrontiers in genetics2021

Association Between a

Shuang Fei, Zeping Gui, Dengyuan Feng, Zijie Wang, Ming Zheng, Hao Chen, Li Sun, Jun Tao, Zhijian Han, Xiaobing Ju and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Shuang FeiDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Zeping GuiDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Dengyuan FengDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Zijie WangDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Ming ZhengDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Hao ChenDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Li SunDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Jun TaoDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Zhijian HanDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Xiaobing JuDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Min GuDepartment of Urology, The Second Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Ruoyun TanDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Xinli LiDepartment of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNSecond Affiliated Hospital of Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

high-throughput sequencingkidney transplantationproteinuriasingle-nucleotide polymorphismsToll-like receptor 2

Identifiers

PMID35265098
PMCPMC8899217
OpenAlexW4213198034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.